ArticleIBRO reports2018

The monoaminergic pathways and inhibition of monoamine transporters interfere with the antidepressive-like behavior of ketamine.

Glauce Socorro de Barros Viana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.